Non-alcoholic fatty liver disease (NAFLD) is the physiological manifestation ... dietary interventions have been investigated for the treatment of this disease, including several polyphenolic ...

Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

Obesity is a chronic disease with many contributing factors ... and nutritionists to help guide and monitor obesity treatment ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US Food and Drug ...

Results from Phase 2b FASCINATE-2 study of denifanstat published in The Lancet Gastroenterology & Hepatology Successful completion of end-of-Phase 2 interactions with FDA on the development of ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

Knee cartilage is not designed for high stress loads. People who are overweight or obese are at a higher risk of developing osteoarthritis because of the extra stress on their knee joints, with many ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...

2 There are currently no treatments approved for MASLD, formerly known as nonalcoholic fatty liver disease. Instead, ...

Obesity is a chronic disease with many contributing factors; family history, access to healthy foods, hormonal and metabolic ...